Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

PHASE3RecruitingINTERVENTIONAL
Enrollment

524

Participants

Timeline

Start Date

September 10, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2027

Conditions
Acute Heart Failure
Interventions
DRUG

Empagliflozin 10 MG

once-daily oral empagliflozin 10 mg

DRUG

Placebo

Placebo matching empagliflozin 10 mg

Trial Locations (61)

Unknown

RECRUITING

Anjo Kosei Hospital, Anjo

RECRUITING

Aichi Medical University Hospital, Nagakute

RECRUITING

Nagoya University Hospital, Nagoya

RECRUITING

Hirosaki University Hospital, Hirosaki

RECRUITING

Hyogo Prefectural Awaji Medical Center, Sumoto

RECRUITING

Funabashi Municipal Medical Center, Funabashi

RECRUITING

Kameda Medical Center, Kamogawa

RECRUITING

Juntendo University Urayasu Hospital, Urayasu

RECRUITING

Fukuokaken Saiseikai Futsukaichi Hospital, Chikushino-shi

RECRUITING

Kurume University Hospital, Kurume

RECRUITING

Ogaki Municipal Hospital, Ōgaki

RECRUITING

Gunma University Hospital, Maebashi

RECRUITING

Kushiro-sanjikai Hospital, Kushiro

RECRUITING

Medical Corporation Sapporo Heart Center, Sapporo

RECRUITING

Sapporo Higashi Tokushukai Hospital, Sapporo

RECRUITING

Tsuchiura Kyodo General Hospital, Tsuchiura

RECRUITING

Iwate Prefectural Cyuou Hospital, Morioka

RECRUITING

Tokai University Hospital, Isehara

RECRUITING

Shonan Kamakura General Hospital, Kamakura

RECRUITING

St.Marianna University School of Medicine Hospital, Kawasaki

RECRUITING

Kochi Medical School Hospital, Nankoku

RECRUITING

Nara Medical University Hospital, Kashihara

RECRUITING

Urasoe General Hospital, Urasoe

RECRUITING

Kindai University Hospital, Sayama

RECRUITING

National Cerebral and Cardiovascular Center Hospital, Suita

RECRUITING

Kasukabe Chuo General Hospital, Kasukabe

RECRUITING

Saitama Medical Center, Kawagoe

RECRUITING

Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi

RECRUITING

Soka City Hospital, Sōka

RECRUITING

Seirei Mikatahara General Hospital, Hamamatsu

RECRUITING

Juntendo University Shizuoka Hospital, Izunokuni

RECRUITING

Saiseikai Utsunomiya Hospital, Utsunomiya

RECRUITING

Nishiarai Hospital, Adachi City

RECRUITING

Mitsui Memorial Hospital, Chiyoda City

RECRUITING

Sakakibara Heart Institute, Fuchū

RECRUITING

Tokyo Medical University Hachioji Medical Center, Hachiōji

RECRUITING

International University of Health and Welfare Mita Hospital, Minato

NOT_YET_RECRUITING

Toranomon Hospital, Minato

RECRUITING

Tokyo Women's Medical University Hospital, Shinjuku

RECRUITING

National Disaster Medical Center, Tachikawa

RECRUITING

Japanese Red Cross Fukuoka Hospital, Fukuoka

RECRUITING

Gifu University Graduate school of Medicine, Gifu

RECRUITING

Hiroshima City Hospital, Hiroshima

RECRUITING

Kitasato University Hospital, Kanagawa

RECRUITING

Chikamori Hospital, Kochi

RECRUITING

Nara Prefecture General Medical Center, Nara

RECRUITING

Sakakibara Heart Institute of Okayama, Okayama

RECRUITING

Nakagami Hospital, Okinawa

RECRUITING

Kitano Hospital, Osaka

RECRUITING

Osaka General Medical Center, Osaka

RECRUITING

Saitama Citizens Medical Center, Saitama

RECRUITING

Tokushima University Hospital, Tokushima

RECRUITING

Juntendo University Hospital, Tokyo

RECRUITING

Juntendo University Nerima Hospital, Tokyo

RECRUITING

Nihon University Itabashi Hospital, Tokyo

RECRUITING

Nippon Medical School Hospital, Tokyo

RECRUITING

St. Luke's International Hospital, Tokyo

RECRUITING

Tokyo General Hospital, Tokyo

RECRUITING

Tokyo Medical University, Tokyo

RECRUITING

Tokyo Metropolitan Bokutoh Hospital, Tokyo

RECRUITING

Yokohama City University Medical Center, Yokohama

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Juntendo University

OTHER

NCT05392764 - Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure | Biotech Hunter | Biotech Hunter